Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Adverse Event Reporting and Recordkeeping for Dietary Supplements as Required by the Dietary Supplement and Nonprescription Drug Consumer Protection Act, 38634 [E9-18532]
Download as PDF
38634
Federal Register / Vol. 74, No. 148 / Tuesday, August 4, 2009 / Notices
Secretary of Health and Human Services
approved for the Council charter to be
renewed. Renewal of the PACHA
charter provides authorization for the
Council to operate until July 27, 2011.
A copy of the Council charter is
available on the PACHA Web site at
https://www.pacha.gov. A copy of the
Council charter also can be obtained by
accessing the FACA database that is
maintained by the Committee
Management Secretariat under the
General Services Administration. The
Web site address for the FACA database
is https://fido.gov/facadatabase.
Dated: July 28, 2009.
Christopher H. Bates,
Interim Executive Director, Presidential
Advisory Council on HIV/AIDS.
[FR Doc. E9–18572 Filed 8–3–09; 8:45 am]
displays a currently valid OMB control
number. OMB has now approved the
information collection and has assigned
OMB control number 0910–0635. The
approval expires on May 31, 2012. A
copy of the supporting statement for this
information collection is available on
the Internet at https://www.reginfo.gov/
public/do/PRAMain.
Dated: July 28, 2009.
Jeffrey Shuren,
Associate Commissioner for Policy and
Planning.
[FR Doc. E9–18532 Filed 8–3–09; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
BILLING CODE 4150–43–P
[60Day–09–09CH]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Proposed Data Collections Submitted
for Public Comment and
Recommendations
Food and Drug Administration
[Docket No. FDA–2007–D–0372]
Agency Information Collection
Activities; Announcement of Office of
Management and Budget Approval;
Adverse Event Reporting and
Recordkeeping for Dietary
Supplements as Required by the
Dietary Supplement and
Nonprescription Drug Consumer
Protection Act
AGENCY:
Food and Drug Administration,
HHS.
mstockstill on DSKH9S0YB1PROD with NOTICES
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing
that a collection of information entitled
Adverse Event Reporting and
Recordkeeping for Dietary Supplements
as Required by the Dietary Supplement
and Nonprescription Drug Consumer
Protection Act has been approved by the
Office of Management and Budget
(OMB) under the Paperwork Reduction
Act of 1995.
FOR FURTHER INFORMATION CONTACT:
Daniel Gittleson, Office of Information
Management (HFA–710), Food and Drug
Administration, 5600 Fishers Lane,
Rockville, MD 20857, 301–796–5156.
SUPPLEMENTARY INFORMATION: In the
Federal Register of September 15, 2008
(73 FR 53252), the agency announced
that the proposed information collection
had been submitted to OMB for review
and clearance under 44 U.S.C. 3507. An
agency may not conduct or sponsor, and
a person is not required to respond to,
a collection of information unless it
VerDate Nov<24>2008
16:07 Aug 03, 2009
Jkt 217001
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Maryam I. Daneshvar,
CDC Acting Reports Clearance Officer,
1600 Clifton Road, MS–D74, Atlanta,
GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
A Controlled Evaluation of Expect
Respect Support Groups (ERSG):
Preventing and Interrupting Teen Dating
Violence among At-Risk Middle and
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
High School Students—New—National
Center for Injury Prevention and Control
(NCIPC), Division of Violence
Prevention (DVP), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
The prevalence and consequences of
teen dating violence make it a public
health concern that requires early and
effective prevention. To date, only three
prevention strategies—Safe Dates, the
Youth Relationships Project, and 4th
R—have demonstrated reductions in
dating violence behaviors in rigorous,
controlled evaluations. In order to
protect young people and build an
evidence-base of effective prevention
strategies, evaluation of additional
programs is needed, including those
programs currently in the field. Expect
Respect Support Groups (provided by
SafePlace) are currently in use in the
Austin Independent School District and
demonstrated promising results in an
uncontrolled program evaluation,
suggesting a controlled evaluation is
warranted to more rigorously examine
program effects. The proposed study has
one primary aim and two exploratory
aims. The primary aim is to evaluate the
effectiveness of Expect Respect Support
Groups (ERSG) to prevent and reduce
teen dating violence and increase
healthy conflict resolution skills
reported by at-risk male and female
middle and high school students
compared to at-risk students in control
schools who do not receive ERSG. The
exploratory aims are: (1) To evaluate
whether or not the effectiveness of
ERSG is enhanced by the presence of a
universal, school-wide prevention
program, and (2) To examine
moderators and mediators of targeted
and universal teen dating violence
interventions, such as biological sex and
history of abuse at intake.
The proposed evaluation will use a
quasi-experimental/non-randomized
design in which a convenience sample
of participants in schools receiving
targeted prevention services are
compared to students in control schools
in which no dating violence prevention
services are available. Control schools
will be selected that have characteristics
(e.g., risk status, socio-economic status)
similar to the Austin Independent
School District intervention schools.
Based on past, uncontrolled program
evaluation of Expect Respect Support
groups, we anticipate that in the Austin
Independent School District and
neighboring district(s), 800 students will
undergo an intake assessment, of whom
600 will be eligible for Expect Respect
Support groups and will complete the
baseline survey. We expect 400 students
E:\FR\FM\04AUN1.SGM
04AUN1
Agencies
[Federal Register Volume 74, Number 148 (Tuesday, August 4, 2009)]
[Notices]
[Page 38634]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-18532]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2007-D-0372]
Agency Information Collection Activities; Announcement of Office
of Management and Budget Approval; Adverse Event Reporting and
Recordkeeping for Dietary Supplements as Required by the Dietary
Supplement and Nonprescription Drug Consumer Protection Act
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing that a
collection of information entitled Adverse Event Reporting and
Recordkeeping for Dietary Supplements as Required by the Dietary
Supplement and Nonprescription Drug Consumer Protection Act has been
approved by the Office of Management and Budget (OMB) under the
Paperwork Reduction Act of 1995.
FOR FURTHER INFORMATION CONTACT: Daniel Gittleson, Office of
Information Management (HFA-710), Food and Drug Administration, 5600
Fishers Lane, Rockville, MD 20857, 301-796-5156.
SUPPLEMENTARY INFORMATION: In the Federal Register of September 15,
2008 (73 FR 53252), the agency announced that the proposed information
collection had been submitted to OMB for review and clearance under 44
U.S.C. 3507. An agency may not conduct or sponsor, and a person is not
required to respond to, a collection of information unless it displays
a currently valid OMB control number. OMB has now approved the
information collection and has assigned OMB control number 0910-0635.
The approval expires on May 31, 2012. A copy of the supporting
statement for this information collection is available on the Internet
at https://www.reginfo.gov/public/do/PRAMain.
Dated: July 28, 2009.
Jeffrey Shuren,
Associate Commissioner for Policy and Planning.
[FR Doc. E9-18532 Filed 8-3-09; 8:45 am]
BILLING CODE 4160-01-S